Jeffrey G. Lamothe - 09 Aug 2022 Form 4 Insider Report for Aptevo Therapeutics Inc. (APVO)

Role
CFO
Signature
/s/ SoYoung Kwon, Attorney-in-Fact
Issuer symbol
APVO
Transactions as of
09 Aug 2022
Net transactions value
$0
Form type
4
Filing time
10 Aug 2022, 16:08:34 UTC
Previous filing
07 Jun 2022
Next filing
30 Jan 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction APVO Restricted Stock Unit Award $0 +5,500 $0.000000 5,500 09 Aug 2022 Common Stock 5,500 Direct F1, F2
transaction APVO Stock Option (right to buy) Award $0 +5,500 $0.000000 5,500 09 Aug 2022 Common Stock 5,500 $4.32 Direct F3
transaction APVO Restricted Stock Unit Award $0 +23,958 $0.000000 23,958 09 Aug 2022 Common Stock 23,958 Direct F1, F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted Stock Units ("RSUs") convert into common stock, $0.001 par value per share, of the Issuer on a one-for-one basis.
F2 The RSUs vest in three approximately equal annual installments beginning on August 8, 2023.
F3 The option vests in three approximately equal annual installments beginning on August 8, 2023.
F4 The RSUs vest in two approximately equal annual installments beginning on August 8, 2023.